← Open Payments lookup

SARAH GATES: Open Payments

NPI 1649951716 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$984 in 41 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $436 · 2025 $984

Food & beverage: $984
CompanyPaymentsAmount
ABBVIE INC.18$442
Otsuka America Pharmaceutical, Inc.9$210
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$139
Teva Pharmaceuticals USA, Inc.3$66
Takeda Pharmaceuticals U.S.A., Inc.2$56
Vanda Pharmaceuticals Inc.1$31
Axsome Therapeutics, Inc.1$23
E.R. Squibb & Sons, L.L.C.1$18

Products named: VRAYLAR, REXULTI, CAPLYTA, AUSTEDO XR, TRINTELLIX, FANAPT, Auvelity, COBENFY.

Industry payments across CO — which companies pay providers there.